Issue 50 • May 2022

Taming the Wild West: regulating digital health apps

Health-related smartphone apps have surged in number and popularity, especially during the pandemic, but they are sparsely monitored. We ask if the sector is in need of regulatory reform

IN DEPTH

Covid-19: Mental health app growth reveals unmet needs

Comment

FDA warns of false results in genetic non-invasive prenatal testing

Briefing

Industry news

Medical industry briefing

Covid-19 briefing

Comment

Russian import of essential medical devices to continue, but in reduced volumes

AI technology impacts gynaecological ultrasound by detecting preterm birth

FDA warns of false results in genetic non-invasive prenatal testing

In Depth

Taming the Wild West: regulating digital health apps

Covid-19: Mental health app growth reveals unmet needs

Remote clinical trial monitoring uptake rises but validation questions swirl

Covid-19 spurred on the self-testing revolution

Is FDA LDT surveillance set to improve as VALID Act heads to resolution?

In Data

Where is trade most likely to be disrupted in the medical industry from the Russian invasion of Ukraine?

How big is the gender pay gap in the medical industry in Britain and who are the worst offenders?

05/23/2024 04:00:51

Contents

Covid-19: Mental health app growth reveals unmet needs

FDA warns of false results in genetic non-invasive prenatal testing